MedPath

comparing the effect of two drugs (Dexmedetomidine and lignocaine) in reducing the rise in heart rate, blood pressure during recovery from anaesthesia

Phase 2/3
Recruiting
Conditions
Age group between 18 and 65years of eithergender belonging to ASAPS 1 or 2 undergoingLaproscopic surgery
Registration Number
CTRI/2018/03/012555
Lead Sponsor
PG Thesis fund KMC Manipal
Brief Summary

The study is Prospective Double blinded Randomized Controlled study. Main aim is to compare the efficacy of intravenous Dexmedetomidine and Lignocaine in attenuating haemodynamic responses to tracheal extubtion and emergence from general anaesthesia. primary outcomes are Heart rate, systolic blood pressure, diastolic blood pressure, mean arterial blood pressure during periextubation period. secondary outcomes is to observe sedation score and time to extubation

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
60
Inclusion Criteria

to ASA-PS I and II undergoing elective laproscopic surgeries requiring general anaesthesia and endotracheal intubation.

Exclusion Criteria

Suspected allergy to study drugs, Difficult airway,.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To observe and compare heart rate, systolic blood pressure, diastolic blood pressure and mean arterial blood pressure in the periextubation periodHeart rate, Systolic, diastolic and mean arterial pressures at intervals | Baseline(just before drug administration) | After 5 min (end of drug administration) | Post extubation at 1, 2, 3, 4, 5 and 10 min.
Secondary Outcome Measures
NameTimeMethod
Ramsay sedation scoreTime to extubaton

Trial Locations

Locations (1)

Kasturba Medical College and Hospital

🇮🇳

Udupi, KARNATAKA, India

Kasturba Medical College and Hospital
🇮🇳Udupi, KARNATAKA, India
Dr Chiranjeevi vallamsetty
Principal investigator
9845544346
drchiru2k7@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.